GRCE - Grace Therapeutics | Financials | Fundamentei

3/2023

2 financials

3/2024

Year	Revenue	EBITDA	Net Inc	Net Mrg	Equity	ROE	Net Debt	ND/EBITDA	OCF SBC	Capex	FCF	Free SBC	EPS
03/2023	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345	$1,345
03/2024	0	-11	-13	L	62	L	-23	-	-13	-0	7	-13	L

To see all financials—including updated, you must be Premium.